col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


134 Results       Page 1

 [1] 
Bentham Science: Current Pharmaceutical Design
  original article Date Title Authors   All Authors
1 [GO] 2025―Mar―20 Identification of Natural Compounds as Potential COVID-19 Main Protease (Mpro) Inhibitors: A Comprehensive Study and In silico Evidence Arti Devi, Vagish Dwibedi, Sahil Jain, Gursharan Kaur, Zaved Ahmed Khan, Sudip Kumar Mandal, et al. (+4)
2 [GO] 2025―Jan―17 Advancing COVID-19 Treatment: The Role of Non-covalent Inhibitors Unveiled by Integrated Machine Learning and Network Pharmacology Saba Qadir, Fahad M. Alshabrmi, Faris F. Aba Alkhayl, Aqsa Muzammil, Snehpreet Kaur, Abdur Rehman
3 [GO] 2025―Jan―06 Virtual Screening Identifies Inhibitors of SARS-CoV-2 Main Protease through Pharmacophore and Similarity Approaches Mohammad A. Khanfar, Mohammad Saleh
4 [GO] 2024―Nov―20 Screening of Natural Compounds as Inhibitor of Mpro SARS-CoV-2 Protein; A Molecular Dynamics Approach Anum Javaid, Nousheen bibi, Malik Siddique Mahmood, Hina Batool, Sana Batool, Arslan Hamid, et al. (+5)
5 [GO] 2024―Nov―15 The Rise of FLiRT Variants in the COVID-19 Pandemic: What We Know So Far Md Sadique Hussain, Gaurav Gupta
6 [GO] 2024―Nov―15 Therapeutic Potential of Neutralizing Monoclonal Antibodies (nMAbs) against SARS-CoV-2 Omicron Variant Pijus Parua, Somnath Ghosh, Koushik Jana, Arnab Seth, Biplab Debnath, Saroj Kumar Rout, et al. (+11)
7 [GO] 2024―Jul―23 Role of Natural Products against the Spread of SARS-CoV-2 by Inhibition of ACE-2 Receptor: A Review Krishana Kumar Sharma, Shoma Devi, Darmendra Kumar, Zeeshan Ali, Nishat Fatma, Raghvendra Mishra, Gajendra Kumar
8 [GO] 2024―Jun―15 An Integrative Network Pharmacology and Bioinformatics Approach for Deciphering the Multi-target Effect of Nyctanthes arbortristis L. against COVID-19 Nagaraja sreeharsha, Girish Meravanige Basavarajappa, Bandar Aloufi, Predeepkumar Narayanappa Shiroorkar, Md. Khalid Anwer, Abdur Rehman
9 [GO] 2024―Apr―30 Ayurvedic and Chinese Herbs against Coronaviruses Amin Gasmi, Sonia Kanwal, Petro Oliinyk, Roman Lysiuk, Mariia Shanaida, Asma Gasmi Benahmed, et al. (+7)
10 [GO] 2024―Apr―03 Why have SGLT2 Inhibitors Failed to Achieve the Desired Success in COVID-19? Medine Cumhur Cure, Erkan Cure
11 [GO] 2024―Mar―25 The Role of Traditional Chinese Medicine and Chinese Pharmacopoeia in the Evaluation and Treatment of COVID-19 Amin Gasmi, Sadaf Noor, Maryam Dadar, Yuliya Semenova, Alain Menzel, Asma Gasmi Benahmed, Geir Bjørklund
12 [GO] 2024―Feb―22 Safety Profile of Paxlovid in the Treatment of COVID-19 Bing Lv, Xin Gao, Guoqiang Zeng, Hui Guo, Faping Li
13 [GO] 2023―Dec―27 Challenging Axillary Lymph-Nodes on PET/CT in Cancer Patients throughout Covid-19 Vaccination Era Alessia Giordano, Rosj Gallicchio, Mariarita Milella, Rebecca Storto, Anna Nardelli, Teresa Pellegrino, et al. (+3)
14 [GO] 2023―Dec―15 Biosensor Detection of COVID-19 in Lung Cancer: Hedgehog and Mucin Signaling Insights Harneet Marwah, Janmejay Pant, Jiten Yadav, Kamal Shah, Hitesh Kumar Dewangan
15 [GO] 2023―Nov―29 Potential Targets and Mechanisms of Bitter Almond-Licorice for COVID-19 Treatment Based on Network Pharmacology and Molecular Docking Qiwei Hong, Xinyue Shang, Yanan Wu, Zhenlin Nie, Bangshun He
16 [GO] 2023―Nov―29 Non-synonymous Single Nucleotide Polymorphisms in Human ACE2 Gene May Affect the Infectivity of SARS-CoV-2 Omicron Subvariants Arijit Samanta, Ashif Ahamed, Syed Sahajada Mahafujul Alam, Safdar Ali, Mohd Shahnawaz Khan, Abdulaziz Mohammed Alamrid, et al. (+2)
17 [GO] 2023―Nov―06 AI-driven Discovery of Celecoxib and Dexamethasone for Exploring their Mode of Action as Human Interleukin (IL-6) Inhibitors to Treat COVID-19-induced Cytokine Storm in Humans Israa M. Shamkh, Mahmoud Elkazzaz, Enas. S. Radwan, Jawayria Najeeb, Md Tabish Rehman, Mohamed F. AlAjmi, et al. (+12)
18 [GO] 2023―Nov―02 Computational Approaches to Designing Antiviral Drugs against COVID-19: A Comprehensive Review Mohan P. Singh, Nidhi Singh, Divya Mishra, Saba Ehsan, Vivek K. Chaturvedi, Anupriya Chaudhary, et al. (+2)
19 [GO] 2023―Oct―26 Exploration of Molecular Targets and Mechanisms of Curcumin in the Treatment of COVID-19 with Depression by an Integrative Pharmacology Strategy Dongwei Zhu, Xianmei Zhou
20 [GO] 2023―Oct―11 The Potential of Cannabidiol for Acute Respiratory Distress Syndrome in COVID-19 Saeid Azimi, Fatemeh Saghafi, Mohammad Hossein Mohammadi, Mohammad Hossein Moghimi, Seyed Ali Akhavan, Masoud khataminia, et al. (+5)
21 [GO] 2023―Sep―06 Salivary antiviral and antibacterial properties in the encounter of SARS-CoV-2 Nooshin Mohtasham, Rahimeh Bargi, Alieh Farshbaf, Maryam Vahabzadeh Shahri, Kiana Kamyab Hesari, Farnaz Mohajertehran
22 [GO] 2023―Aug―16 Acute Kidney Injury (AKI) in COVID-19: In silico Identification of LncRNA-MiRNA-Gene Networks and Key Transcription Factors Somayeh Hashemi Sheikhshabani, Zeinab Amini-Farsani, Nesa Kazemifard, Parastoo Modarres, Sharareh Khazaei Feyzabad, Zahra Amini-Farsani, et al. (+3)
23 [GO] 2023―Jul―30 Nanotechnology-based Approaches and Investigational Therapeutics against COVID-19
24 [GO] 2023―Jul―30 Repositioning Therapeutics for SARS-CoV-2: Virtual Screening of Plant-based Anti-HIV Compounds as Possible Inhibitors against COVID-19 Viral RdRp
25 [GO] 2023―May―17 Electroacupuncture in Regulating Gastrointestinal Symptoms of COVID-19: A Mini-review Xianqiang Yu, Yingjie Wang
26 [GO] 2023―May―11 Exploring the potential mechanism of action of ursolic acid against gastric cancer and COVID-19 using network pharmacology and bioinformatics analysis Hailiang Huang, Zhiyao Liu, Ying Yu, Yuqi Jia, Lingling Li, Xin Shi, Fangqi Wang
27 [GO] 2023―Jan―03 Experimental and Computational Approaches for SARS-CoV-2 Theranostics Ijaz Gul, Mohammad Amjad Kamal
28 [GO] 2022―Dec―21 In-Silico Study of Resveratrol as Multi-Edged Potent Inhibitor against SARS-Cov-2 and Variants of Concern Using Molecular Dynamic Simulation and PCA Analysis Amaresh Kumar Sahoo, Vishal Singh, Vidhu Agarwal, Pritish Kumar Varadwaj
29 [GO] 2022―Dec―07 Therapeutic Applications of Fucoidans and their Potential to Act against COVID-19 Dhananjay Yadav, Minseok Song
30 [GO] 2022―Dec―06 In Silico Studies Reveal Antiviral Effects of Traditional Indian Spices on COVID-19 Brijesh Kumar
31 [GO] 2022―Dec―06 Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19) Evellyn Claudia Wietzikoski Lovato
32 [GO] 2022―Dec―06 Use of Natural Compounds as a Potential Therapeutic Agent Against COVID-19 Shadma Wahab
33 [GO] 2022―Dec―06 Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19 Yasanandana S. Wijayasinghe
34 [GO] 2022―Dec―06 Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19 Md. Tabish Rehman
35 [GO] 2022―Dec―06 Prevention Knowledge and Its Practice Towards COVID-19 Among General Population of Saudi Arabia: A Gender-based Perspective Freah Alshammary
36 [GO] 2022―Dec―06 COVID-19 and Domestic Animals: Exploring the Species Barrier Crossing, Zoonotic and Reverse Zoonotic Transmission of SARS-CoV-2 Rajesh Kumar
37 [GO] 2022―Dec―06 Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments Clodoveo Ferri
38 [GO] 2022―Dec―06 The Association of Respiratory Viruses with Oxidative Stress and Antioxidants. Implications for the COVID-19 Pandemic Marina Darenskaya
39 [GO] 2022―Dec―06 Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients Kholoud F. Aliter
40 [GO] 2022―Dec―06 Therapeutic Management of COVID-19 Patients: Clinical Manifestation and Limitations Urooj Fatima
41 [GO] 2022―Dec―06 COVID-19 Vaccines in Clinical Trials and their Mode of Action for Immunity against the Virus Shima Tavakol
42 [GO] 2022―Dec―06 Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management Hussien Ahmed H. Abdelgawad
43 [GO] 2022―Dec―06 Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Khojasteh Malekmohammad
44 [GO] 2022―Dec―06 miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis Rohit Satyam
45 [GO] 2022―Dec―06 Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm Monireh Torabi-Rahvar
46 [GO] 2022―Dec―06 Natural Agents Modulating ACE-2: A Review of Compounds with Potential against SARS-CoV-2 Infections Arquimedes Gasparotto Junior
47 [GO] 2022―Nov―24 Host-Cell Surface Binding Targets in SARS-COV-2 for Drug Design Sayyed Abbas Tabatabai, Hanieh Maleksabet, Elham Rezaee
48 [GO] 2022―Nov―08 Current insights and molecular docking studies of the drugs under clinical trial as rdrp inhibitors in COVID-19 treatment Amita Verma, Pradeep Kumar, Irine Pauly, Ankit Kumar Singh, Adarsh Kumar, Yogesh Singh, et al. (+2)
49 [GO] 2022―Oct―28 Mast Cell's Role in Cytokine Release Syndrome and Related Manifestations of COVID-19 Disease Öner Özdemir, Azize Yasemin Göksu Erol, Ümmügülsüm Dikici
50 [GO] 2022―Oct―26 Nitric oxide and its derivatives containing nasal spray and inhalation therapy for the treatment of COVID-19 Vivek P Chavda, Lalitkumar K Vora, Rajeev K. Singla, Aayushi B. Patel, Priyal Shah, Vladimir N. Uversky, Vasso Apostolopoulos
51 [GO] 2022―Oct―21 Vaccination against SARS-CoV-2 protects from COVID-19-induced endothelial dysfunction Evangelos Oikonomou, Stamatios Lampsas, Nektarios Souvaliotis, Savvas Sarantos, Gerasimos Siasos, Garyphallia Poulakou, et al. (+10)
52 [GO] 2022―Oct―20 State-of-the-art tools to elucidate the therapeutic potential of TAT-peptide (TP) conjugated repurposing drug against SARS-CoV-2 spike glycoproteins Mohammad Azam Ansari, Mohammad N. Alomary, Qazi Mohammad Sajid Jamal, Yosif Almoshari, Ahmed Salawi, Suliman A. Alhmahmoud, Johra Khan
53 [GO] 2022―Oct―18 Use of Natural Compounds as a Potential Therapeutic Agent Against COVID-19 Shadma Wahab
54 [GO] 2022―Oct―18 COVID-19 Outbreak and Emerging Management through Pharmaceutical Therapeutic Strategy Md. Rahman
55 [GO] 2022―Oct―18 COVID-19 Vaccines in Clinical Trials and their Mode of Action for Immunity against the Virus Shima Tavakol
56 [GO] 2022―Sep―27 Clinical Consideration for Mesenchymal Stem Cells in Treatment of COVID-19 Kang-Hsi Wu, Yu-Hua Chao, Te-Fu Weng, Ju-Pi Li
57 [GO] 2022―Sep―09 Tetraspanin-enriched Microdomain Containing CD151, CD9, and TSPAN 8 - Potential Mediators of Entry and Exit Mechanisms in Respiratory Viruses Including SARS-CoV-2 RamaRao Malla, Mohammad Amjad Kamal
58 [GO] 2022―Aug―02 Herbal medicines as potential inhibitors of SARS-CoV-2 infection Soodabeh Rostami, Shima Gharibi, Hajar Yaghoobi, Zary Nokhodian, Parisa Shoaei, Armina Alaghband Bahrami, et al. (+2)
59 [GO] 2022―Aug―01 COVID-19: Pathophysiology, transmission, and drug development for therapeutic treatment and vaccination strategies Vishal Kumar Singh, Himani Chaurasia, Richa Mishra, Ritika Srivastava, Aditya K. Yadav, Jayati Dwivedi, et al. (+2)
60 [GO] 2022―Jul―22 Cytokine Release Syndrome in Pathogenesis and Treatment of COVID-19 Tao Hu, Chi Hin Cho
61 [GO] 2022―Jul―22 An Update on Promising Agents against COVID-19: Secondary Metabolites and Mechanistic Aspects Maryam Jamshidnia, Robert D. E. Sewell, Mahmoud Rafieian-Kopaei
62 [GO] 2022―Jul―17 Natural Agents Modulating ACE-2: A Review of Compounds with Potential against SARS-CoV-2 Infections Gasparotto A.
63 [GO] 2022―Jul―14 A review of current evidence from cardiovascular manifestations and outcomes in patients with COVID-19 Shirin Saberianpour, Elahe Aleebrahim-Dehkordi, Elaheh Mazaheri, Ali Hasanpour-Dehkordi
64 [GO] 2022―Jul―14 Prolonged NHE Activation may be Both Cause and Outcome of Cytokine Release Syndrome in COVID-19 Medine Cumhur Cure, Erkan Cure
65 [GO] 2022―Jul―14 Therapeutic potential of P2X7 purinergic receptor modulation in the main organs affected by the COVID-19 cytokine storm Júlia Leão Batista Simões, Leilane Dayane Sobierai, Stefany Maciel Pereira, Miriam Vitória Rodrigues dos Santos, Margarete Dulce Bagatini
66 [GO] 2022―Jul―04 COVID-19 Challenge: A Quest for Effective Vaccine Strategies Against Circulating and Emerging SARS-CoV-2 Variants Ruchika Yogesh, Noopur Srivastava, Syed Nasir Abbas Bukhari
67 [GO] 2022―Jun―21 Prevalence and death rate of COVID-19 in systemic autoimmune diseases in the first three pandemic waves. Relationship to disease subgroups and ongoing therapies Clodoveo Ferri, Vincenzo Raimondo, Laura Gragnani, Dilia Giuggioli, Lorenzo Dagna, Antonio Tavoni, et al. (+78)
68 [GO] 2022―Jun―07 Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part V) Mohammad Amjad Kamal, Md Asaduzzaman Khan
69 [GO] 2022―May―27 Main Diagnostic Methods for Covid-19: Integrative Review Ana Sara Martins de Campos, Giandra Azolini Fernandes de Souza, Renan Almeida de Jesus, Giuliana Zardeto, Guilherme Donadel, Mariana Dalmagro, et al. (+7)
70 [GO] 2022―May―22 Immunopathogenesis and immunogenetic variants in COVID-19 Pakorn Sagulkoo, Kitiporn Plaimas, Apichat Suratanee, Andrea Name Colado Simão, Edna Maria Vissoci Reiche, Michael Maes
71 [GO] 2022―May―07 Can we s쳮d in the fight against SARS-CoV-2 with its emerging new variants? Shima Tavakol, Hani Tavakol, Mo S. Alavijeh, Alexander Seifalian
72 [GO] 2022―Apr―30 Repositioning therapeutics for SARS-CoV-2: Virtual screening of plant-based Anti-HIV compounds as possible inhibitors against COVID-19 viral RdRp Mahadevamurthy Murali, Hittanahallikoppal Gajendramurthy Gowtham, Mohammad Azam Ansari, Mohammad N. Alomary, Saad Alghamdi, Mazen Almehmadi, et al. (+6)
73 [GO] 2022―Apr―20 Interaction of Vitamin D and Corticosteroid Use in Hospitalized COVID-19 Patients: A Potential Explanation for Inconsistent Findings in the Literature Jimmy T. Efird, Ethan Anderson, Charulata Jindal, Ayako Suzuki
74 [GO] 2022―Mar―29 Ivabradine in the management of COVID-19-related cardiovascular complications: A perspective Tomas Baka, Kristina Repova, Ivan Luptak, Fedor Simko
75 [GO] 2022―Mar―23 Alterations in clinical characteristics of blood donors post COVID-19 recovery Fahad Al Ghamdi, Salma Naqvi, Fahad A. Alabassi, Sultan Alhayyani, Mirza Rafi Baig, Vikas Kumar, Firoz Anwar
76 [GO] 2021―Dec―13 A review of the rational and current evidence on colchicine for COVID-19 Hazem S. Ghaith, Mohamed Diaa Gabra, Mohamed H. Nafady, Hamza Emad Elshawah, Ahmed Negida, Mohammad Amjad Kamal
77 [GO] 2021―Oct―22 Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part IV) Md Asaduzzaman Khan, Mohammad Amjad Kamal
78 [GO] 2021―Oct―21 Covid-19 Epidemiology, Pathogenesis and Therapy Alessandro Antonelli, Clodoveo Ferri
79 [GO] 2021―Oct―14 Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part III) Md Asaduzzaman Khan, Mohammad Amjad Kamal
80 [GO] 2021―Sep―03 Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments Clodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, Massimo L’Andolina, Lorenzo Dagna, Antonio Tavoni, et al. (+79)
81 [GO] 2021―Sep―01 Nanotechnology-Based Strategies for the Management of COVID-19: Recent Development and Challenges Ritu Singh, Monalisha Behera, Nisha Kumari, Sanjeev Kumar, Vishnu D. Rajput, Tatiana M Minkina, et al. (+3)
82 [GO] 2021―Sep―01 The Use of Lectins as Tools to Combat SARS-CoV-2 Daniela Martinez, Diego Amaral, David Markovitz, Luciano Pinto
83 [GO] 2021―Jul―16 Synopsis on Pharmotechnological Approaches in Diagnostic to Management Strategies in Fighting Against COVID-19 Asim Azhar, Nazia Hassan, Manvi Singh, Khaled Al-hosaini, Mohammad Amjad Kamal
84 [GO] 2021―Jul―06 Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Khojasteh Malekmohammad, Mahmoud Rafieian-Kopaei
85 [GO] 2021―Jul―05 Nanotechnology-Based Approaches and Investigational Therapeutics against COVID-19 Md. Mominur Rahman, Muniruddin Ahmed, Mohammad Touhidul Islam, Md. Robin Khan, Sharifa Sultana, Saila Kabir Maeesa, et al. (+6)
86 [GO] 2021―Jun―10 Different Methods for Molecular and Rapid Detection of Human Novel Coronavirus Mohamad Hesam Shahrajabian, Wenli Sun, Qi Cheng
87 [GO] 2021―Jun―09 The roles of vitamin D in increasing the body's immunity and reducing injuries due to viral infections: With an emphasis on its possible role in SARS-CoV-2 (COVID-19) Elahe Aleebrahim-Dehkordi, Niloofar Deravi, Shirin Yaghoobpoor, Dariush Hooshyar, Mahmoud Rafieian-Kopaei
88 [GO] 2021―May―22 Preventive and Therapeutic Strategies to Fight COVID-19 Alexander Marcus Seifalian, Shima Tavakol
89 [GO] 2021―Mar―24 Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part II) Md Asaduzzaman Khan, Mohammad Amjad Kamal
90 [GO] 2021―Mar―16 Tocilizumab: From Rheumatic Diseases to Covid-19 Alberto Raiteri, Fabio Piscaglia, Alessandro Granito, Francesco Tovoli
91 [GO] 2021―Mar―03 Identification of the interaction between Angiotensin-converting Enzyme Residues and Severe Acute Respiratory Syndrome Coronavirus 2. Youness Kadil, Mohammed Mouhcine, Imane Rahmoune, Houda Filali
92 [GO] 2021―Mar―03 Diabetes and COVID-19; a review of possible mechanisms Reyhaneh Moradi-Marjaneh, Fereshteh Asgharzadeh, Elnaz Khordad, Mahdi Moradi Marjaneh
93 [GO] 2021―Feb―25 COVID-19: Epidemiology, Pathology, Diagnosis, Treatment, and Impact Saimon Shahriar, Md. Sohel Rana, Md. Sabbir Hossain, Ariful Karim, Tasneem Nayla Mredula, Nadia Nourin, et al. (+2)
94 [GO] 2021―Feb―23 The association of respiratory viruses with oxidative stress and antioxidants. Implications for the COVID-19 pandemic Marina Darenskaya, Liubov Kolesnikova, Sergei Kolesnikov
95 [GO] 2021―Feb―04 Nano-Biomaterials as Sensing and Therapeutic Tool to Mitigate Viral Pathogenesis with Special Reference to COVID-19 Pallavi Singh Chauhan, Dhananjay Yadav, Anuj Dubey, Jun-O Jin
96 [GO] 2021―Jan―26 The computational intervention of macrolide antibiotics in the treatment of COVID-19 Firoz Anwar, Hisham N. Altayb, Fahad A. Al-Abbasi, Vikas Kumar, Mohammad Amjad Kamal
97 [GO] 2021―Jan―26 Emerging therapeutic approaches to COVID-19 Indrakant Kumar Singh, Pratibha Kumari, Pooja Mittal, Amit Kumar, Bharti Singal, Gulam Mustafa Hasan, et al. (+4)
98 [GO] 2021―Jan―18 Therapeutic agents against COVID-19 with clinical evidence Cheng Tian, Ming Xiang
99 [GO] 2021―Jan―18 Natural agents modulating ACE-2: A review of compounds with potential against SARS-CoV-2 infections Arquimedes Gasparotto Junior, Sara Emília Lima Tolouei, Francislaine Aparecida dos Reis Lívero, Francielli Gasparotto, Thaise Boeing, Priscila de Souza
100 [GO] 2021―Jan―12 In silico Prediction and Designing of Potential siRNAs to be Used as Antivirals Against SARS-CoV-2 Sayed Sartaj Sohrab, Sherif Aly El-Kafrawy, Aymn T. Abbas, Leena H. Bajrai, Esam Ibraheem Azhar
101 [GO] 2021―Jan―12 Natural Products, a Potential Therapeutic Modality in Management and Treatment of nCoV-19 Infection: Preclinical and Clinical based Evidence Ashif Iqubal, Mohammad Kashif Iqubal, Musheer Ahmed, Syed Ehtaishamul Haque
102 [GO] 2021―Jan―04 COVID-19: An Update on Pathogenesis and Treatment Marwa Abduallah AL Dhamen, Abrar Fouad Alhashim, Hawra Hussain Alqattan, Faheem Hyder Pottoo
103 [GO] 2021―Jan―04 Emergence and Reemergence of Human Coronaviruses: Spike Protein as the Potential Molecular Switch and Pharmaceutical Target Fahim Ahmad, Mohammad A. Kamal, Babu L. Tekwani
104 [GO] 2021―Jan―03 Use of Natural Compounds as a potential therapeutic agent against COVID-19 Shadma Wahab, Irfan Ahmad, Safia Irfan, Mohammad Hassan Baig, Abd-ElAziem Farouk, Jae-Jun Dong
105 [GO] 2020―Dec―24 In silico studies reveal antiviral effects of traditional Indian spices on COVID-19 Brijesh Kumar, Sama Zaidi, Shafiul Haque, Nandita Dasgupta, Arif Hussain, Sreepoorna Unni, et al. (+2)
106 [GO] 2020―Dec―23 A Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management Hussien Ahmed, Ahmed Sayed, Malak Munir, Mostafa H. Elberry, Ibrahim M Sayed, Mohammed Amjad Kamal, et al. (+3)
107 [GO] 2020―Dec―14 An Overview of Natural and Synthetic Analogs of Quinoline for the Prophylaxis of COVID-19. Chloroquine Analogs: An Overview of Natural and Synthetic Quinolines as Broad Spectrum Antiviral Agents Veera Bramhachari Pallaval, Manasa Kanithi, Sangeetha Meenakshisundaram, Achanta Jagadeesh, Mattareddy Alavala, Thanigaimalai Pillaiyar, et al. (+2)
108 [GO] 2020―Dec―11 Anti-malarial Drugs are Not Created Equal for SARS-CoV-2 Treatment: A Computational Analysis Evidence Simone Ronsisvalle, Federica Panarello, Rosaria Di Mauro, Renato Bernardini, Giovanni Li Volti, Giuseppina Cantarella
109 [GO] 2020―Dec―11 Silybin B and Cianidanol Inhibit M pro and Spike Protein of SARS-CoV-2: Evidence from in Silico Molecular Docking Studies Rashi Srivastava, Shubham Tripathi, Sreepoorna Unni, Arif Hussain, Shafiul Haque, Nandita Dasgupta, et al. (+2)
110 [GO] 2020―Dec―05 COVID-19 Impacts, Diagnosis and Possible Therapeutic Techniques: A Comprehensive Review Ayesha Aziz, Muhammad Asif, Ghazala Ashraf, Qiaoli Yang, Shenqi Wang
111 [GO] 2020―Dec―03 Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A new Route to Fight against COVID-19? Shah Khalid, Faisal A. Almalki, Taibi Ben Hadda, Ammar Bader, Tareq Abu-Izneid, Malika Berredjem, et al. (+2)
112 [GO] 2020―Nov―30 Viral Diseases and Natural Products: Prospects in COVID-19 Treatment Mohammad Amjad Kamal, Md Asaduzzaman Khan
113 [GO] 2020―Nov―26 Therapeutic management of COVID-19 patients: Clinical manifestation and limitations Urooj Fatima, Syed Saif Abbas Rizvi, Neha Raina, Saher Fatima, Safikur Rahman, Mohammad Amjad Kamal, Md. Imtaiyaz Hassan
114 [GO] 2020―Nov―26 Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm Monireh Torabi-Rahvar, Nima Rezaei
115 [GO] 2020―Nov―20 Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19 Yasanandana Supunsiri Wijayasinghe, Pravin Bhansali, Ronald E. Viola, Mohammad A. Kamal, Nitesh Kumar Poddar
116 [GO] 2020―Nov―20 Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19 Md Tabish Rehman, Mohamed F. AlAjmi, Afzal Hussain
117 [GO] 2020―Nov―20 COVID-19 and domestic animals: Exploring the species barrier crossing, zoonotic and reverse zoonotic transmission of SARS-CoV-2 Rajesh Kumar, Seetha Harilal, Abdullah G. Al-Sehemi, Mehboobali Paninipara, Tapan Behl, Githa Elizabeth Mathew, Bijo Mathew
118 [GO] 2020―Nov―20 Coronavirus Disease -2019 (COVID-19) in 2020: A Perspective Study of a Global Pandemic Mujtaba Aamir Bhat, Safikur Rahman, Irfan Ahmad Rather, Iqbal Banday, Shafiya Syed, Hamira Koser, et al. (+3)
119 [GO] 2020―Nov―20 The impact of traditional plants and their secondary metabolites in the discovery of COVID-19 treatment Shabana Bibi, Ayesha Sarfraz, Ghazala Mustafa, Zeeshan Ahmed, Muhammad Aurang Zeb, Yuan-Bing Wang, et al. (+4)
120 [GO] 2020―Nov―06 Current landscape of natural products against coronaviruses: perspectives in COVID-19 treatment and antiviral mechanism Jakaria Shawon, Zakia Akter, Md. Munnaf Hossen, Yeasmin Akter, Abu Sayeed, Md Junaid, et al. (+2)
121 [GO] 2020―Nov―06 Properties of Ethno-Medicinal Plants and Their Bioactives-Possible Use for Prevention and Treatment of COVID-19: A Review Ambreen Shoaib, Lubna Azmi, Ila Shukla, Saad S. Alqahtani, Ibrahim A. Alsarra, Faiyaz Shakeel
122 [GO] 2020―Oct―26 COVID-19 Vaccines on Clinical Trials and their Mode of Action for Immunity against the Virus Shima Tavakol, Mo S. Alavijeh, Alexander M. Seifalian
123 [GO] 2020―Oct―16 The undiscovered potential of essential oils for treating SARS-CoV-2 (COVID- 19) Peter J. Wilkin, Minnatallah Al-Yozbaki, Alex George, Girish Kumar Gupta, Cornelia M. Wilson
124 [GO] 2020―Oct―02 miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis Rohit Satyam, Tulika Bhardwaj, Sachin Goel, Niraj Kumar Jha, Saurabh Kumar Jha, Parma Nand, et al. (+3)
125 [GO] 2020―Oct―01 Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients Kholoud F. Aliter, Rami A. Al-Horani
126 [GO] 2020―Sep―11 Emerging Novel Coronavirus is a Global Threat: Insight in the Biology of COVID-19 and its Hijacking Process of Hosts’ Cell Debmalya Roy, Ipshita Khanra, Zeling Wang, Siva Bharath Merugu, Fakhar-un-Nisa Yunus, Dhahiri Saidi Mashausi, Dawei Li
127 [GO] 2020―Sep―03 Targeting Natural Products for the Treatment of COVID-19 - An Updated Review Ramachandra Reddy Pamuru, Naveen Ponneri, Amooru G Damu, Ramakrishna Vadde
128 [GO] 2020―Aug―26 Emergence of human pathogenic Coronaviruses: Lectins as antivirals for SARS-CoV-2 Sayed Sartaj Sohrab, Mohd Suhail, Mohammad Amjad Kamal, Fahim Ahmad, Esam Ibraheem Azhar
129 [GO] 2020―Aug―26 Neutralization of SARS-CoV-2 Spike Protein via Natural Compounds: A Multi Layered High Throughput Virtual Screening Approach Anupam Dhasmana, Vivek Kumar Kashyap, Swati Dhasmana, Sudhir Kotnala, Shafiul Haque, Ghulam Md Ashraf, et al. (+3)
130 [GO] 2020―Aug―19 Prevention Knowledge and Its Practice Towards COVID-19 Among General Population of Saudi Arabia: A Gender-based Perspective Freah Alshammary, Ammar Ahmed Siddiqui, Junaid Amin, Muhammad Ilyas, Hassaan Anwer Rathore, Ibne Hassan, et al. (+2)
131 [GO] 2020―Aug―13 Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the “Cytokine Release (Storm) Syndrome” Caused by SARS-CoV-2? Francisco José López-Iranzo, Ana María López-Rodas, Luis Franco, Gerardo López-Rodas
132 [GO] 2020―Jul―22 A Case Study: Analysis of Patents of Coronaviruses and Covid-19 for Technology Assesment and Future Research Pankaj Musyuni, Geeta Aggarwal, Manju Nagpal, Ramesh K. Goyal
133 [GO] 2020―Jul―14 Current Status of the COVID-19 Outbreak and Emerging Management through Pharmaceutical Therapeutic Strategy Tapan Behl, Md. Habibur Rahman, Rokeya Akter, Md. Arifur Rahman Chowdhury, Manirujjaman Mohammed, Israt Jahan Bulbul, et al. (+2)
134 [GO] 2020―Jul―07 Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19) Evellyn Claudia Wietzikoski Lovato, Lorena Neris Barboza, Samantha Wietzikoski, Amanda Nascimento Vasques de Souza, Pablo Alvarez Auth, Arquimedes Gasparotto Junior, Francislaine Aparecida dos Reis Lívero
 [1] 

134 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec